| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director, 16.4% Owner
1 company
Todd S Thomson is Director, 10% Owner at ACTU. Todd S Thomson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $317K at current prices.
The ACTU filings lean toward selling, a net 298,750 shares.
Todd S Thomson has 5 Form 4 filings on record from August 2024 to October 2026, all as Director at Actuate Therapeutics, Inc. Common stock (ACTU), 2024–2026.
The 19 reported transactions were 9 conversions, 7 option or other derivative awards, 2 open-market sales and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $1.8M.
The largest open-market sale was 280,000 shares of ACTU at an average $5.80 on January 5, 2026, about $1.6M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.